181 related articles for article (PubMed ID: 11107126)
1. Retinoic-acid-resistant neuroblastoma cell lines show altered MYC regulation and high sensitivity to fenretinide.
Reynolds CP; Wang Y; Melton LJ; Einhorn PA; Slamon DJ; Maurer BJ
Med Pediatr Oncol; 2000 Dec; 35(6):597-602. PubMed ID: 11107126
[TBL] [Abstract][Full Text] [Related]
2. Retinoid therapy of high-risk neuroblastoma.
Reynolds CP; Matthay KK; Villablanca JG; Maurer BJ
Cancer Lett; 2003 Jul; 197(1-2):185-92. PubMed ID: 12880980
[TBL] [Abstract][Full Text] [Related]
3. Differentiating agents in pediatric malignancies: retinoids in neuroblastoma.
Reynolds CP
Curr Oncol Rep; 2000 Nov; 2(6):511-8. PubMed ID: 11122886
[TBL] [Abstract][Full Text] [Related]
4. Retinoid therapy of childhood cancer.
Reynolds CP; Lemons RS
Hematol Oncol Clin North Am; 2001 Oct; 15(5):867-910. PubMed ID: 11765378
[TBL] [Abstract][Full Text] [Related]
5. Retinoic acid and TGF-β signalling cooperate to overcome MYCN-induced retinoid resistance.
Duffy DJ; Krstic A; Halasz M; Schwarzl T; Konietzny A; Iljin K; Higgins DG; Kolch W
Genome Med; 2017 Feb; 9(1):15. PubMed ID: 28187790
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxicity and molecular activity of fenretinide and metabolites in T-cell lymphoid malignancy, neuroblastoma, and ovarian cancer cell lines in physiological hypoxia.
Song MM; Makena MR; Hindle A; Koneru B; Nguyen TH; Verlekar DU; Cho H; Maurer BJ; Kang MH; Reynolds CP
Anticancer Drugs; 2019 Feb; 30(2):117-127. PubMed ID: 30272587
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation.
Ponzoni M; Bocca P; Chiesa V; Decensi A; Pistoia V; Raffaghello L; Rozzo C; Montaldo PG
Cancer Res; 1995 Feb; 55(4):853-61. PubMed ID: 7850799
[TBL] [Abstract][Full Text] [Related]
8. Comparison of N-(4-hydroxyphenyl)retinamide and all-trans-retinoic acid in the regulation of retinoid receptor-mediated gene expression in human breast cancer cell lines.
Kazmi SM; Plante RK; Visconti V; Lau CY
Cancer Res; 1996 Mar; 56(5):1056-62. PubMed ID: 8640761
[TBL] [Abstract][Full Text] [Related]
9. Fenretinide-induced caspase-8 activation and apoptosis in an established model of metastatic neuroblastoma.
Raguénez G; Mühlethaler-Mottet A; Meier R; Duros C; Bénard J; Gross N
BMC Cancer; 2009 Mar; 9():97. PubMed ID: 19331667
[TBL] [Abstract][Full Text] [Related]
10. Retinoic acid enhances killing of neuroblastoma cells by Newcastle disease virus.
Reichard KW; Lorence RM; Katubig BB; Peeples ME; Reyes HM
J Pediatr Surg; 1993 Oct; 28(10):1221-5; discussion 1225-6. PubMed ID: 8263678
[TBL] [Abstract][Full Text] [Related]
11. Is growth inhibition and induction of apoptosis in lung cancer cell lines by fenretinide [N-(4-hydroxyphenyl)retinamide] sufficient for cancer therapy?
Ohlmann CH; Jung C; Jaques G
Int J Cancer; 2002 Aug; 100(5):520-6. PubMed ID: 12124800
[TBL] [Abstract][Full Text] [Related]
12. The MYCN inhibitor BGA002 restores the retinoic acid response leading to differentiation or apoptosis by the mTOR block in MYCN-amplified neuroblastoma.
Lampis S; Raieli S; Montemurro L; Bartolucci D; Amadesi C; Bortolotti S; Angelucci S; Scardovi AL; Nieddu G; Cerisoli L; Paganelli F; Valente S; Fischer M; Martelli AM; Pasquinelli G; Pession A; Hrelia P; Tonelli R
J Exp Clin Cancer Res; 2022 Apr; 41(1):160. PubMed ID: 35490242
[TBL] [Abstract][Full Text] [Related]
13. The impact of retinoic acid treatment on the sensitivity of neuroblastoma cells to fenretinide.
Armstrong JL; Martin S; Illingworth NA; Jamieson D; Neilson A; Lovat PE; Redfern CP; Veal GJ
Oncol Rep; 2012 Jan; 27(1):293-8. PubMed ID: 21964808
[TBL] [Abstract][Full Text] [Related]
14. All-trans-retinoic acid induces nuclear factor kappaB activation and matrix metalloproteinase-9 expression and enhances basement membrane invasivity of differentiation-resistant human SK-N-BE 9N neuroblastoma Cells.
Farina AR; Masciulli MP; Tacconelli A; Cappabianca L; De Santis G; Gulino A; Mackay AR
Cell Growth Differ; 2002 Aug; 13(8):343-54. PubMed ID: 12193473
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of neuroblastoma enhances Bcl-2 expression and induces alterations of apoptosis and drug resistance.
Lasorella A; Iavarone A; Israel MA
Cancer Res; 1995 Oct; 55(20):4711-6. PubMed ID: 7553653
[TBL] [Abstract][Full Text] [Related]
16. Combinational treatment with retinoic acid derivatives in non-small cell lung carcinoma in vitro.
Choi EJ; Whang YM; Kim SJ; Kim HJ; Kim YH
J Korean Med Sci; 2007 Sep; 22 Suppl(Suppl):S52-60. PubMed ID: 17923756
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity in retinoic acid signaling in neuroblastomas: Role of matrix metalloproteinases in retinoic acid-induced differentiation.
Joshi S; Guleria RS; Pan J; Dipette D; Singh US
Biochim Biophys Acta; 2007 Sep; 1772(9):1093-102. PubMed ID: 17611083
[TBL] [Abstract][Full Text] [Related]
18. Influence of isomerisation on the growth inhibitory effects and cellular activity of 13-cis and all-trans retinoic acid in neuroblastoma cells.
Veal GJ; Errington J; Redfern CP; Pearson AD; Boddy AV
Biochem Pharmacol; 2002 Jan; 63(2):207-15. PubMed ID: 11841795
[TBL] [Abstract][Full Text] [Related]
19. Enhanced potency of 9-cis versus all-trans-retinoic acid to induce the differentiation of human neuroblastoma cells.
Han G; Chang B; Connor MJ; Sidell N
Differentiation; 1995 Jul; 59(1):61-9. PubMed ID: 7589896
[TBL] [Abstract][Full Text] [Related]
20.
Maeshima R; Moulding D; Stoker AW; Hart SL
Nucleic Acid Ther; 2020 Aug; 30(4):237-248. PubMed ID: 32240058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]